BLOG - UNBOUNCE - EXAMPLE PAGE - ANNUAL REPORT - KCH - Flipbook - Page 53
Notes to the financial statements
2020/21 comparatives
At 1
April
2020
£’000
Income Expenditure
£’000
£’000
Gains/
(Losses)
£’000
Transfers
£’000
At 31
March
2021
£’000
Restricted funds
Cancer treatment
and research
244
-
-
-
-
244
Paediatric liver
laboratories
248
77
(140)
-
1
186
2,453
-
-
-
3
2,456
264
95
(88)
-
62
333
-
743
(634)
-
-
109
201
11
-
-
-
212
3,410
926
(862)
-
66
3,540
Clinical funds
8,160
1,439
(1,424)
-
(37)
8,138
Social investment
3,525
-
-
-
(3,525)
-
Fund for strategic
grants
1,903
-
-
-
5,000
6,903
Development of
capital projects
1,000
-
-
-
-
1,000
14,588
1,439
(1,424)
-
1,438
16,041
2,773
1,336
(2,014)
5,175
(1,504)
5,766
Total unrestricted
funds
17,361
2,775
(3,438)
5,175
(66)
21,807
Total funds
20,771
3,701
(4,300)
5,175
-
25,347
David Hughes
Special Trust
Transforming Liver
Care (TLC) Appeal
COVID-19 support
Other funds less
than £100k
Total restricted
funds
Unrestricted funds
Designated
Total designated
funds
General funds
Transfers include an internal allocation to each designated and restricted fund equivalent to interest earned
based on the average value of the fund during the year.
K I N G’ S CO L L E G E H O S P I TA L C H A R I T Y A N N UA L R E P O R T A N D F I N A N C I A L S TAT E M E N T S 2 0 2 1 / 2 2
53
